Safety of switching to Migalastat from enzyme replacement...

  • Main
  • 2019 / 03
  • Safety of switching to Migalastat from enzyme replacement...

Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study

Hughes, Derralynn A., Nicholls, Kathleen, Sunder‐Plassmann, Gere, Jovanovic, Ana, Feldt‐Rasmussen, Ulla, Schiffmann, Raphael, Giugliani, Robert, Jain, Vipul, Viereck, Chris, Castelli, Jeffrey P., Skub
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
American Journal of Medical Genetics Part A
DOI:
10.1002/ajmg.a.61105
Date:
March, 2019
File:
PDF, 721 KB
2019
Conversion to is in progress
Conversion to is failed